Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggression
alcohol
alcohol, neurologic complications with
altered states of consciousness, driving with
amphetamines
anemia
anger
angiography, cerebral
anxiety
arterial dissection
arterial dissection, carotid
arterial dissection, vertebral
attention span
automobile accidents
binge drinking
blood pressure
cannabinoids
cannabinoids, synthetic
cannabis withdrawal syndrome
CAT scan
CAT scan, abnormal
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, multiple
cerebrovascular accident, non atherosclerotic cause of
cerebrovascular accident, recurrent
cerebrovascular accident, silent
cerebrovascular accident, women
cerebrovascular accident, young adult
cocaine
cognition
complications
cyclic vomiting
defecation
delirium
designer drugs
diarrhea
dilantin
dilantin, toxicity
driving
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug withdrawal
gender
glue sniffing
hallucinogens
headache
headache, precipitating factors
headache, recurrent
headache, severe
headache, thunderclap
hepatitis
heralding manifestation
inattention
intellectual deficit
intracerebral hemorrhage
LSD
marihuana
marihuana, bad trips with
marihuana, intravenous use of
marijuana, medical
medical-legal aspects of neurology
memory
memory, defect of recent
memory, impairment of
mortality
MRI
MRI, abnormal
MRI, angiography
MRI, angiography, false negative
myocardial infarction
nasal decongestant
nausea and vomiting
neurologic disease
neurologic examination, focal
neurotoxic
nicotine
nicotine patch
pheochromocytoma
posterior leukoencephalopathy syndrome
postpartum
practice guidelines
precipitating factors
prognosis
psychiatric disorder
psychological testing
psychosis
psychotic behavior
reversible cerebral vasoconstrictive syndromes
reversible neurologic disorder
review article
risk factors
safety
seizure
selective serotonin reuptake inhibitors
sleep pathology and physiology
spice
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
sweating
thrombocytopenia
toxic encephalopathy
transient global amnesia, precipitating events
transient ischemic attack
treatment of neurologic disorder
uremia
urine test in toxic screen
vasculopathy
vasoactive substances
vasospasm
vasospasm, cerebral
vomiting, intractable
Showing articles 750 to 800 of 1482 << Previous Next >>

Investigating Suspected Cerebral Venous Thrombosis
BMJ 334:794-795, Smit,R. &Hourihan,M.D., 2007

Guidelines for the Early Management of Adults With Ischemic Stroke
Stroke 38:1655-1711, Adams,H.P.,et al, 2007

Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007

Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007

Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007

Intra-arterial Therapies for Acute Ischemic Stroke
Neurol 68:2132-2139, Mandava,P. &Kent,T.A., 2007

Consent for Intravenous Thrombolysis in Acute Stroke
Arch Neurol 64:785-792, White-Bateman,S.R.,et al, 2007

Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007

Intravenous Immunoglobulin Therapy Markedly Ameliorates Muscle Weakness and Severe Pain in Proximal Diabetic Neuropathy
JNNP 78:899-901, Kawagashira,Y.,et al, 2007

Acute Ischemic Stroke
NEJM 357:572-529, Bart van der Worp,H. &van Gijn,J., 2007

Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Stroke 38:2633-2639,2627, Ogawa,A.,et al, 2007

Prediction of Hemorrhagic Transformation After Recanalization Therapy Using T2*-Permeability Magnetic Resonance Imaging
Ann Neurol 62:170-176, Bang,O.Y.,et al, 2007

Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients
Storke 38:2738-2744, Fiehler,J.,et al, 2007

MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows
Stroke 38:2640-2645, Schellinger,P.D.,et al, 2007

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke 38:2612-2618, De Keyser,J.,et al, 2007

Long-Term Outcome After Thrombolysis in Telemedical Stroke Care
Neurol 69:898-903,819, Schwab,S.,et al, 2007

Intratumoral Hemorrhage After Thrombolsyis in a Patient With Glioblastoma Multiforme
Neurol 69:936, Grimm,S.A. &DeAngelis,L.M., 2007

Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial rtPA Treatment of Acute Ischemic Stroke in the IMS I and II Trials
AJNR 28:1890-1894, King,S.,et al, 2007

Multifocal Motor Neuropathy: The Diagnostic Spectrum and Response to Treatment
Neurol 69:1680-1687, Slee,M.,et al, 2007

Randomized Trial of IV Dexamethasone for Acute Migraine in the Emergency Department
Neurol 69:2038-2044, Friedmna,B.W.,et al, 2007

Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment
Stroke 38:3213-3217, Juhl,J.,et al, 2007

Door to Thrombolysis: ER Reorganization and Reduced Delays to Acute Stroke Treatment
Neurol 67:334-336, Lindsberg,P.J.,et al, 2006

Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study
Neurol 67:340-342, Misra,U.K.,et al, 2006

Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke
Stroke 37:2168-2169, Wiese,K.M.,et al, 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Pro
Stroke 37:2436-2437,2440, Schellinger,P.D. &Hacke,W., 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Con
Stroke 37:2438-2439,2440, Ford,G.A., 2006

Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis
Stroke 37:2301-2305, Rubiera,M.,et al, 2006

Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006

Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
Stroke 37:2463-2466, Neumann-Haefelin,T.,et al, 2006

Safety of Cerebral Digital Subtraction Angiography in Children, Complication Rate Analysis in 241 Consecutive Diagnostic Angiograms
Stroke 37:2535-2539, Burger,I.M.,et al, 2006

An Expedited Code Stroke Protocol Is Feasible and Safe
Stroke 37:2935-2939,2863, Sattin,J.A.,et al, 2006

The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006

Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke 37:2963-2969, Kent,D.M.,et al, 2006

Long-Term Effect of Intra-Arterial Thrombolysis in Stroke
Stroke 37:3002-3007, Nedeltchev,K.,et al, 2006

Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006

Prediction of Thrombolytic Efficacy in Acute Ischemic Stroke Using Thin-Section Noncontrast CT
Neurol 67:1846-1848, Kim,E.Y.,et al, 2006

Outcome of Acute Vertebrobasilar Occlusions Treated with Intra-Arterial Fibrinolysis in 180 Patients
AJNR 27:2042-2047, Schulte-Altedorneburg,G.,et al, 2006

Predicting Abnormal Coagulation in Ischemic Stroke: Reducing Delay in rt-PA Use
Neurol 67:1665-1667, Gottesman,R.F.,et al, 2006

Seizures During Stroke Thrombolysis Heralding Dramatic Neurologic Recovery
Neurol 67:2048-2049, Rodan,L.H.,et al, 2006

Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
Stroke 37:1822-1827, Audebert,H.,et al, 2006

Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006

Human Botulism Immune Globulin for the Treatment of Infant Botulism
NEJM 354:462-471, Arnon,S.S.,et al, 2006

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006

Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006

Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke 37:419-424, Choi,J.H.,et al, 2006

Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006

First-Pass Quantitiative CT Perfusion Identifies Thresholds for Salvageable Penumbra in Acute Stroke Patients Treated with Intra-arterial Therapy
AJNR 27:20-25, Schaefer,P.W.,et al, 2006



Showing articles 750 to 800 of 1482 << Previous Next >>